Corona Remedies IPO GMP Today
Corona Remedies IPO opens on 8 December 2025. Corona Remedies IPO GMP is Rs 342.00 today. Listing price estimate is Rs 1,404.00 (issue price Rs 1,062.00). Listing gain estimate: 32.20%.
Issue Price
Rs 1,062.00
GMP Today
Rs 342.00
GMP %
+32.20%
Listing Price
Rs 1,404.00
Listing Gain / Lot
Rs 4,788.00
Listing Date
15 Dec 2025
Corona Remedies IPO GMP Day Wise
GMP for Corona Remedies IPO started at Rs 0 on 2 December 2025 and stood at Rs 291 on 11 December 2025. The sharpest single-day jump was from Rs 0 on 2 Dec 2025 to Rs 307 on 3 Dec 2025. The upward move through the subscription window usually reflects building demand across investor categories rather than a one-day spike.
| Date | Issue Price | GMP | Listing Price | Estimated Profit |
|---|---|---|---|---|
| 11 Dec 2025Today | Rs 1,062.00 | Rs 291.00 | Rs 1,353.00 (+27.40%) | Rs 4,074.00 |
| 10 Dec 2025 | Rs 1,062.00 | Rs 295.00 | Rs 1,357.00 (+27.78%) | Rs 4,130.00 |
| 9 Dec 2025 | Rs 1,062.00 | Rs 270.00 | Rs 1,332.00 (+25.42%) | Rs 3,780.00 |
| 8 Dec 2025 | Rs 1,062.00 | Rs 262.00 | Rs 1,324.00 (+24.67%) | Rs 3,668.00 |
| 7 Dec 2025 | Rs 1,062.00 | Rs 290.00 | Rs 1,352.00 (+27.31%) | Rs 4,060.00 |
| 6 Dec 2025 | Rs 1,062.00 | Rs 305.00 | Rs 1,367.00 (+28.72%) | Rs 4,270.00 |
| 5 Dec 2025 | Rs 1,062.00 | Rs 365.00 | Rs 1,427.00 (+34.37%) | Rs 5,110.00 |
| 4 Dec 2025 | Rs 1,062.00 | Rs 365.00 | Rs 1,427.00 (+34.37%) | Rs 5,110.00 |
| 3 Dec 2025 | Rs 1,062.00 | Rs 307.00 | Rs 1,369.00 (+28.91%) | Rs 4,298.00 |
| 2 Dec 2025 | Rs 1,062.00 | Rs 0.00 | Rs 1,062.00 (+0.00%) | Rs 0.00 |
Corona Remedies IPO Listing Price
Based on today's GMP, Corona Remedies IPO listing price estimate is Rs 1,404.00 per share (issue price Rs 1,062.00 + GMP Rs 342.00).
Actual listing price will be known on 15 December 2025 when the stock lists on NSE/BSE.
Corona Remedies IPO Listing Gain
Lot size: 14 shares
GMP today: Rs 342.00
Estimated listing gain per lot: Rs 342.00 × 14 = Rs 4,788.00
A GMP of around 32.2% is a strong positive signal from the grey market. Investors are pricing in a meaningful listing premium over the issue price.
GMP has moved up over the tracked period. Steady increases through the subscription window are usually a stronger signal than a single-day spike.
GMP is unofficial. Listing gain can differ on listing day.
Corona Remedies IPO Subscription Status
GMP and subscription numbers often move together. When institutional and HNI demand is strong, grey market participants usually price in a higher premium. Current overall subscription for Corona Remedies IPO is 144.49x. Compare this with the GMP trend to see if demand aligns. The GMP move around 3 Dec 2025 may reflect how the market reacted once the subscription window activity picked up after 8 Dec 2025.
See live figures on the Corona Remedies IPO Subscription Status page.
Corona Remedies IPO Details
| Field | Value |
|---|---|
| Price Band | ₹1008.0 - ₹1062.0 |
| Issue Size | ₹655.37 Cr |
| Lot Size | 14 shares |
| IPO Type | Mainboard |
| Open Date | 8 Dec 2025 |
| Close Date | 10 Dec 2025 |
| Listing Date | 15 Dec 2025 |
| Subscription | 144.49x |
Corona Remedies IPO full details (financials, peers, review).
About Corona Remedies IPO
Corona Remedies Limited is an India-focused branded pharmaceutical company specializing in developing and marketing products across high-growth chronic therapeutic areas, primarily women’s healthcare, cardio-diabeto, pain management, and urology. The company is recognized as the second-fastest-growing among the top 30 firms in the Indian Pharmaceutical Market (IPM) by domestic sales. It operates two manufacturing facilities in Gujarat and Himachal Pradesh and leverages a pan-India marketing network of 2,671 medical representatives.
Corona Remedies IPO GMP FAQs
What is Corona Remedies IPO IPO GMP today?
Corona Remedies IPO IPO GMP is ₹342 as of 20 July 2026, 11:01 AM IST. At issue price ₹1,062, that is +32.20% expected listing gain in the grey market.
What is Corona Remedies IPO IPO grey market premium (GMP)?
The grey market premium (GMP) for Corona Remedies IPO IPO is ₹342 today. GMP is the unofficial premium traders pay above the issue price of ₹1,062 before listing on NSE/BSE.
What is Corona Remedies IPO IPO expected returns?
Corona Remedies IPO IPO expected returns based on today's GMP are +32.20% over the issue price of ₹1,062. Estimated listing price is ₹1,404 per share. Actual listing gain on 15 December 2025 may differ.
What is the estimated listing price of Corona Remedies IPO IPO?
Based on today's GMP, Corona Remedies IPO IPO estimated listing price is ₹1,404 per share (issue price ₹1,062 + GMP ₹342). The actual listing price will be set on 15 December 2025 when trading starts.
What is the expected profit per lot in Corona Remedies IPO IPO?
At GMP of ₹342 and lot size of 14 shares, estimated grey market profit is ₹4,788 (1 lot × 14 shares × ₹342). This is unofficial and not guaranteed on listing day.
Will Corona Remedies IPO IPO list at GMP price?
Corona Remedies IPO IPO may list around ₹1,404 based on current GMP of ₹342, but listing at exact grey market price is not guaranteed. GMP is unofficial. On 15 December 2025, the opening price depends on market sentiment, final subscription, and index levels.
What is Corona Remedies IPO IPO issue price and lot size?
Corona Remedies IPO IPO issue price is ₹1,062 per share (price band ₹1008.0 - ₹1062.0). Lot size is 14 shares. Minimum application is 1 lot.
When is Corona Remedies IPO IPO listing date?
Corona Remedies IPO IPO listing date is 15 December 2025. The stock is expected to list on NSE and BSE on that day. GMP can change until listing.
What is Corona Remedies IPO IPO GMP high and low?
Corona Remedies IPO IPO GMP made a high of ₹365 on 5 Dec 2025 and a low of ₹0 on 2 Dec 2025 in tracked grey market data.
Can Corona Remedies IPO IPO GMP change after subscription closes?
Yes. Corona Remedies IPO IPO closed on 10 December 2025. GMP often moves between the close date and listing date (15 December 2025) based on allotment buzz, market mood, and news. Check this page for the latest GMP before listing.
What is Corona Remedies IPO IPO subscription status?
Live category-wise subscription for Corona Remedies IPO IPO is on the Corona Remedies IPO Subscription Status page on IPOwiz, including QIB, NII, and retail figures.
How to check Corona Remedies IPO IPO allotment status?
Allotment for Corona Remedies IPO IPO can be checked on the Corona Remedies IPO Allotment Status page on IPOwiz, on the registrar website, BSE allotment page, or the IPOwiz App using your PAN.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. GMP verified before publish.